In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
about
Antibiotic treatment of animals infected with Borrelia burgdorferiEffectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.Review of treatment options for lyme borreliosis.In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin GClarithromycin in treatment of early Lyme disease: a pilot studyComparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agentsFuture directions in antimicrobial chemotherapy.Evaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine modelSpectrum of activity of azithromycin.The activity of azithromycin in animal models of infection.In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.Erythromycin resistance in Borrelia burgdorferi.In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferiEfficacy of clarithromycin for treatment of experimental Lyme disease in vivo.In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.Roxithromycin in the treatment of Lyme disease--update and perspectives.Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.
P2860
Q24650857-3FA59BEA-8183-4A0B-AEE8-2E13A05F2930Q33754842-98DCB028-3F0E-4DEA-84A3-59A04FAD2E84Q34471224-B72C1E8F-1558-4AC2-9676-BD2F2051026AQ35118043-E747E502-6C23-45FF-A8B1-BB053BE68B87Q35122553-7507E465-F098-4EF6-82EA-7197ADBB7792Q35281053-E9AE2E8D-D4CB-46AF-8124-D423E5E91414Q35530705-ADB68598-0D10-4F1A-9A0C-591A7227700CQ35547622-0A534566-50D5-4A4C-9F61-80BF998FF959Q36454256-B91D7783-34EC-4FCA-92D1-A741C3AC4610Q36454260-797B5191-871A-4065-9D61-05B23B267C11Q37248535-68697E7A-2306-4C9B-BA8A-0D9B06BB3152Q39657790-D78A62AC-3C29-4A29-85FC-348D6BD2AA00Q39779771-80268CE9-826E-4775-8B6A-E052284E0362Q39866191-2C207D72-1CEE-4268-98B0-20A3FBC754A2Q39866294-23D12E6C-8ACD-4DBE-BCEF-CA78793A0B55Q42183764-FB67A4A7-FADA-47D4-B806-EE246380C538Q42686268-285CA448-9FB5-4793-8531-8BA525559567Q52550672-F53AA49A-8591-44D5-A4DB-3833CED183AD
P2860
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
@en
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
@nl
type
label
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
@en
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
@nl
prefLabel
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
@en
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
@nl
P2093
P356
P1476
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
@en
P2093
P356
10.1093/JAC/25.SUPPL_A.33
P407
P478
25 Suppl A
P577
1990-01-01T00:00:00Z